14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.48 $4.41 Friday, 3rd May 2024 EVAX stock ended at $3.95. This is 1.54% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.64% from a day low at $3.85 to a day high of $3.99.
90 days $2.82 $4.74
52 weeks $0.470 $13.55

Historical Evaxion Biotech A/S prices

Date Open High Low Close Volume
Dec 08, 2023 $0.680 $0.695 $0.620 $0.695 39 257
Dec 07, 2023 $0.660 $0.689 $0.620 $0.689 40 783
Dec 06, 2023 $0.640 $0.680 $0.620 $0.680 102 103
Dec 05, 2023 $0.770 $0.770 $0.547 $0.600 760 739
Dec 04, 2023 $0.81 $0.82 $0.750 $0.82 46 502
Dec 01, 2023 $0.82 $0.82 $0.772 $0.82 43 312
Nov 30, 2023 $0.82 $0.89 $0.720 $0.799 289 006
Nov 29, 2023 $0.768 $0.82 $0.765 $0.780 34 074
Nov 28, 2023 $0.80 $0.86 $0.792 $0.792 266 441
Nov 27, 2023 $0.84 $0.85 $0.777 $0.81 17 240
Nov 24, 2023 $0.788 $0.86 $0.750 $0.86 16 592
Nov 22, 2023 $0.768 $0.80 $0.768 $0.80 9 498
Nov 21, 2023 $0.81 $0.85 $0.700 $0.80 110 867
Nov 20, 2023 $0.85 $0.85 $0.767 $0.767 61 608
Nov 17, 2023 $0.786 $0.786 $0.727 $0.730 12 806
Nov 16, 2023 $0.723 $0.780 $0.723 $0.750 101 440
Nov 15, 2023 $0.750 $0.760 $0.711 $0.745 124 342
Nov 14, 2023 $0.680 $0.780 $0.680 $0.714 44 356
Nov 13, 2023 $0.735 $0.735 $0.663 $0.689 99 118
Nov 10, 2023 $0.700 $0.750 $0.690 $0.750 56 902
Nov 09, 2023 $1.00 $1.03 $0.716 $0.736 206 015
Nov 08, 2023 $1.16 $1.16 $1.03 $1.05 87 827
Nov 07, 2023 $1.20 $1.20 $1.12 $1.17 50 967
Nov 06, 2023 $1.20 $1.20 $1.10 $1.11 133 322
Nov 03, 2023 $1.09 $1.17 $1.05 $1.14 97 552
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT